A study published today in Genome Medicine describes a framework for returning ‘secondary’ or ‘incidental’ genomic findings to patients. We… Read more »
If you had a condition that could be treated with a single operation that carries risks, or with a series of physiotherapy sessions, which has fewer… Read more »
The news last month that genetic testing company 23andMe has suspended its marketing activities after intervention by the US Food… Read more »
Later this year, Genome Medicine will publish a new thematic series focusing on Participatory Medicine. This article collection… Read more »